Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CSL Behring Begins Trial to Evaluate Monoclonal Antibody for Respiratory Distress

americanpharmaceuticalreviewJuly 16, 2020

Tag: CSL Behring , CSL312 , COVID-19

PharmaSources Customer Service